Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
MGHL Stock Summary
In the News
G.research Hosts Its Inaugural Micro-Cap Conference
RYE, N.Y.--(BUSINESS WIRE)--G.research will host its inaugural Micro-Cap Symposium on May 18, 2021. The conference will be held virtually. This research meeting will feature presentations by senior management spanning various sectors. Investors should contact their salesperson for more information or to register. Participating Companies Lakeland Industries (NASDAQ: LAKE) Citius Pharmaceuticals (NASDAQ: CTXR) Western Copper & Gold (NYSEAMERICAN: WRN) CareCloud (NASDAQ: MTBC) Trecora Resour
MGHL Financial details
MGHL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 16.59 | 7.39 | 4.96 | 3.35 | |
Net income per share | -1.23 | -3.42 | -2.38 | -2.62 | -1.58 | |
Operating cash flow per share | -1.49 | -4.25 | -3.07 | -2.85 | -1.01 | |
Free cash flow per share | -1.49 | -4.25 | -3.07 | -2.85 | -1.01 | |
Cash per share | 2.86 | 11.82 | 7.91 | 4.81 | 3.81 | |
Book value per share | 3.02 | 10.83 | 7.68 | 5.06 | 3.48 | |
Tangible book value per share | 3.02 | 10.83 | 7.68 | 5.06 | 3.48 | |
Share holders equity per share | 3.02 | 10.83 | 7.68 | 5.06 | 3.48 | |
Interest debt per share | 0.05 | 0 | 0 | 0 | 0 | |
Market cap | 453.85K | 34.16M | 4.2M | 1.29M | 1.2M | |
Enterprise value | 324.22K | 27.58M | -545.77K | -1.6M | -1.09M | |
P/E ratio | -8.14 | -17.92 | -2.94 | -0.82 | -1.26 | |
Price to sales ratio | 0 | 3.7 | 0.95 | 0.43 | 0.6 | |
POCF ratio | -6.71 | -14.42 | -2.28 | -0.76 | -1.99 | |
PFCF ratio | -6.71 | -14.42 | -2.28 | -0.76 | -1.99 | |
P/B Ratio | 3.32 | 5.66 | 0.91 | 0.42 | 0.58 | |
PTB ratio | 3.32 | 5.66 | 0.91 | 0.42 | 0.58 | |
EV to sales | 0 | 2.98 | -0.12 | -0.54 | -0.54 | |
Enterprise value over EBITDA | -5.61 | -11.51 | 0.34 | 1.03 | 1.17 | |
EV to operating cash flow | -4.79 | -11.64 | 0.3 | 0.94 | 1.8 | |
EV to free cash flow | -4.79 | -11.64 | 0.3 | 0.94 | 1.8 | |
Earnings yield | -0.12 | -0.06 | -0.34 | -1.22 | -0.79 | |
Free cash flow yield | -0.15 | -0.07 | -0.44 | -1.32 | -0.5 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 2.24 | 2.75 | 2.93 | 1.85 | 2.46 | |
Current ratio | 617.52 | 3.72 | 5.37 | 2.81 | 2.46 | |
Interest coverage | -27.95 | 0 | 0 | 0 | 0 | |
Income quality | 1.21 | 1.24 | 1.29 | 1.09 | 0.64 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.21 | 0.34 | 0.54 | 0.51 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | -0.07 | 0 | 0 | |
Stock based compensation to revenue | 0 | -78.94 | -57.3 | 6.46 | -123.11 | |
Graham number | 9.13 | 28.88 | 20.29 | 17.26 | 11.13 | |
ROIC | -0.39 | -0.32 | -0.31 | -0.52 | -0.45 | |
Return on tangible assets | -0.41 | -0.23 | -0.26 | -0.36 | -0.28 | |
Graham Net | 2.85 | 9.61 | 6.75 | 3.15 | 2.39 | |
Working capital | 136.87K | 5.71M | 4.35M | 2.33M | 1.95M | |
Tangible asset value | 136.87K | 6.04M | 4.61M | 3.04M | 2.09M | |
Net current asset value | 136.87K | 5.71M | 4.35M | 2.33M | 1.95M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 511.85K | 713.08K | 392.6K | 512.17K | |
Average payables | 2.61K | 111 | 0 | 0 | 0 | |
Average inventory | 0 | 98.54K | 98.54K | 0 | 0 | |
Days sales outstanding | 0 | 40.41 | 33.12 | 46.97 | 116.43 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 7.44 | 0 | 0 | 0 | |
Receivables turnover | 0 | 9.03 | 11.02 | 7.77 | 3.14 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 49.08 | 0 | 0 | 0 | |
ROE | -0.41 | -0.32 | -0.31 | -0.52 | -0.45 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.69 | 1.02 | 0.83 | 0.78 | 0.81 | |
Net income per share | 651.2 | -0.1 | -845.42 | -0.63 | -0.39 | |
Operating cash flow per share | -0.19 | -0.17 | 0.11 | -1.38 | -0.38 | |
Free cash flow per share | -0.19 | -0.17 | 0.11 | -1.38 | -0.38 | |
Cash per share | 3.97 | 3.81 | 3.92 | 2.53 | 2.15 | |
Book value per share | 3.58 | 3.48 | 3.02 | 2.38 | 2 | |
Tangible book value per share | 3.58 | 3.48 | 3.02 | 2.38 | 2 | |
Share holders equity per share | 3.58 | 3.48 | 3.02 | 2.38 | 2 | |
Interest debt per share | 0 | 0 | 844.95 | 0 | 0 | |
Market cap | 960.14K | 1.2M | 972.15K | 690.1K | 660.1K | |
Enterprise value | -1.43M | -1.09M | -1.38M | -829.84K | -629.45K | |
P/E ratio | 0 | -4.86 | 0 | -0.45 | -0.71 | |
Price to sales ratio | 2.32 | 1.95 | 1.96 | 1.47 | 1.36 | |
POCF ratio | -8.35 | -12.03 | 14.88 | -0.83 | -2.87 | |
PFCF ratio | -8.35 | -12.03 | 14.88 | -0.83 | -2.87 | |
P/B Ratio | 0.45 | 0.58 | 0.54 | 0.48 | 0.55 | |
PTB ratio | 0.45 | 0.58 | 0.54 | 0.48 | 0.55 | |
EV to sales | -3.45 | -1.77 | -2.77 | -1.77 | -1.29 | |
Enterprise value over EBITDA | 7.65 | 21.85 | 5.03 | 2.2 | -2.52 | |
EV to operating cash flow | 12.39 | 10.87 | -21.11 | 1 | 2.73 | |
EV to free cash flow | 12.39 | 10.87 | -21.11 | 1 | 2.73 | |
Earnings yield | 407 | -0.05 | -521.86 | -0.55 | -0.35 | |
Free cash flow yield | -0.12 | -0.08 | 0.07 | -1.2 | -0.35 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 12.81 | 46.02 | 8.58 | 4.03 | -5.16 | |
Current ratio | 2.47 | 2.46 | 2.22 | 2.19 | 73.34 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.61 | 1.62 | -0.24 | 2.19 | 0.99 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.51 | 0.35 | 0.54 | 0.73 | 0.41 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | -403.24 | 7.62 | 0 | 0 | |
Graham number | 229.05 | 2.84 | 239.57 | 5.83 | 4.17 | |
ROIC | 181.86 | -0.03 | -280.19 | -119.36K | -432.6 | |
Return on tangible assets | 112.16 | -0.02 | -157.84 | -0.15 | -0.12 | |
Graham Net | 2.45 | 2.39 | 2.1 | 1.36 | 1.14 | |
Working capital | 1.96M | 1.95M | 1.72M | 1.3M | 1.27M | |
Tangible asset value | 2.15M | 2.09M | 1.81M | 1.43M | 1.2M | |
Net current asset value | 1.96M | 1.95M | 1.72M | 1.3M | 523.37K | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 521.66K | 600.8K | 530.83K | 466.09K | 362K | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 121.94 | 94.03 | 76.04 | 98.28 | 39.16 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.74 | 0.96 | 1.18 | 0.92 | 2.3 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 181.86 | -0.03 | -280.19 | -0.27 | -0.19 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
MGHL Frequently Asked Questions
What is Morgan Group Holding Co. stock symbol ?
Morgan Group Holding Co. is a US stock , located in Rye of Ny and trading under the symbol MGHL
What is Morgan Group Holding Co. stock quote today ?
Morgan Group Holding Co. stock price is $0.9528 today.
Is Morgan Group Holding Co. stock public?
Yes, Morgan Group Holding Co. is a publicly traded company.